The pregnant women living with hiv antiretroviral therapy coverage for pmtct in the Central African Republic is currently 39%, a decrease of 11% (-22.0%) compared to 2021.
Pregnant women living with HIV antiretroviral therapy coverage for PMTCT in the Central African Republic
No matching regions
Source:
Data availability:
Regions:
215
Date range: 2000 to 2022
Points:
13,760
Measure:
%
Similar regions to the Central African Republic
PMTCT antiretroviral therapy coverage
More indicators for the Central African Republic
Male unintentional poisoning
4.2
-0.2
(2019)
Female wasting in children
4.9%
-0.9%
(2019)
Female prevalence of HIV
1.8%
0%
(2022)
Out-of-pocket expenditure PPP per capita
intl dollar42
+intl dollar1
(2021)
Birth registration
44.8%
-16.2%
(2019)
Contraceptive modern method prevalence
14.4%
+3.1%
(2019)
Central African Republic PMTCT antiretroviral therapy coverage between 2000 and 2022
| Period | PMTCT antiretroviral therapy coverage | Change |
|---|---|---|
| 2022 | 39% | -11% |
| 2021 | 50% | +2% |
| 2020 | 48% | -6% |
| 2019 | 54% | +10% |
| 2018 | 44% | +4% |
| 2017 | 40% | -15% |
| 2016 | 55% | +16% |
| 2015 | 39% | +4% |
| 2014 | 35% | +15% |
| 2013 | 20% | -14% |
| 2012 | 34% | +3% |
| 2011 | 31% | +7% |
| 2010 | 24% | -4% |
| 2009 | 28% | +7% |
| 2008 | 21% | +4% |
| 2007 | 17% | 0% |
| 2006 | 17% | +11% |
| 2005 | 6% | +4% |
| 2004 | 2% | +2% |
| 2003 | 0% | 0% |
| 2002 | 0% | -1% |
| 2001 | 1% | +1% |
| 2000 | 0% |